Abstract
OTC Distribution in Europe 2010 edition is an in-depth strategic 18 country
study. It defines and explores the main themes of change running through the
European region and shows how they will influence the channel strategies for
manufacturers' of non-prescription and OTC self-medication as well associated
consumer healthcare products.
It provides a wealth of knowledge covering 18 European markets together with
insights into an increasingly competitive and complex marketing channel
structure from a highly respected healthcare strategy consultant James W.
Dudley
This is the seventh edition of James W Dudley' s highly regarded 18 country
consultancy study - OTC Distribution in Europe. This much expanded 2010
edition is the largest and most up to date strategic analysis of the supply
network serving the non-prescription pharmaceuticals and OTC Self-medication
in Europe with over
15 Chapters 460 pages and over 200 graphs, tables & figures
"This study has identified themes of change that are reshaping the structure
of the European healthcare supply chain, focusing buyer power and presenting
suppliers with new strategic challenges.
The aim of this seventh study into OTC Distribution in Europe is to explore
these themes and to provide a reasoned framework for anticipating unfolding
threats and opportunities".
James W. Dudley
OTC Distribution in Europe 2010 edition is a study of the factors driving
change and presenting challenges and opportunities to healthcare
manufacturers. It includes analysis and discussion of European and national
statutory and regulatory developments; healthcare supply chain economics;
evolving formal and informal channel structures; distribution channel
competitors' market shares, linkages and groupings.
OTC Distribution in Europe 2010 edition is an analysis of changes in
manufacturer, retail customer and consumer and patient needs and the unfolding
strategies required by healthcare companies to adapt and lead Europe' s
self-medication markets. The 2010 study provides insights and understanding of
inter-channel rivalries between pharmacy and the mass market operators and the
need for retail pharmacy chains or voluntary groups to force the pace of
innovation. This is needed to challenge emerging competing channels including
supermarkets, mail order pharmacies and the Internet.
OTC Distribution in Europe 2010 edition shows how the pharmaceutical supply
chain is concentrating around key players together with the emergence of new
business models that are transforming major pharmaceutical distributors
including Celesio, Alliance Boots, Phoenix, Mediq and others from wholesalers
to structured international channel managers. OTC Distribution in Europe 2010
edition provides up-to-date statistics, analysis, insights, discussion and
opinions regarding the historic, present and future challenges and
opportunities for the European non-prescription and OTC self medication market
together with consumer healthcare and pharmaceutical market data, pricing and
distributor market shares
Executive Summary
In 2010 European consumers are expected to purchase nearly $37.5 billion worth
of non-prescription OTC medicines for self-medication representing around 36%
of world demand. Accounting for 16% of retail pharmaceutical business in the
region non-prescription self-medication is an important business category for
both manufacturers and retailers.
Yet a number of major factors are coming into play which will influence the
competitive environment for the consumer healthcare industry. Among these are
the restructuring of the pharmaceutical supply chain, continued deregulation
of retail channels, the growing importance of retail pharmacy groupings and
mass market chains and the expansion of products licensed for sale in
non-pharmacy outlets. These factors together will have a major impact on how
manufacturers plan their strategies over the next few years.
OTC Medicine Manufacturers will have to find strategic responses at both
national and international levels to a number of critical issues some of which
include: -
- Future processes of deregulation of the pharmacy supply chain in the light
of revised actions from the European Commission and the judgements by the
European Court of Justice affecting pharmacy ownership in Germany, France,
Spain, Austria and Sweden
- Continuing concentration of pharmaceutical wholesaler' s buying power and
vertical integration into retailing and logistics across European borders
- The expansion of a Europe-wide retail pharmacy footprint of ' virtual' and
wholly owned chains connected to a handful of key wholesalers
- Recovery prospects for the non-prescription sector in Western Europe and
its future in Eastern States in the light of healthcare reforms and the
maturity of some core categories leading to changes to industry structures
with an increasing shift to brand driven consumer marketing cultures
- The ambitions of mass market grocery and chain discount drugstore
operators to enter the lucrative consumer health market through GSL brands
and pharmacy and OTC unit in-plants
- The expansion of international retailers from Central and Eastern Europe
into the European consumer health and beauty markets The spread of pharmacy
chains and the introduction of general sale lists(GSL) to the Nordic Region
- The continuing legacy of healthcare reforms in Europe' s largest market,
Germany, especially the impact on consumer confidence and perceptions of
non-prescription medicines following the abolition of reimbursement and
resale price maintenance on OTC medicines, legalization of mail order and
Internet marketing of pharmaceuticals and the benefits and costs of partial
deregulation of pharmacy ownership - especially in terms of increased
pharmacy numbers, improved profitability and the surge in affiliations to
voluntary or virtual pharmacy chains.
"This 18 country study has identified many of the unfolding strategic issues within the supply chain that will impact on individual OTC Self-medication companies as both challenges and opportunities "
OTC Distribution in Europe - 2010 edition [Report] - Europe, Pharmacies ,
Chains, Future, Channel, OTC Medicines, Non-prescription, Self-medication,
Licensed medicines, Unlicensed medicines, Regulation, Distribution, Market
Research, Trends, Forecasts, Pharmaceutical Wholesalers, Druggist and
Drugstore chains, Consumer behaviour, Analysis, Regulatory, Rx to OTC ,
General Sale List, GSL, Author James W Dudley
| 
View Cart
